Switch On Your HIV Smarts.

Webinar: PrEP and Young Black Gay Men

, by San Francisco AIDS Foundation

Recent research has shown that young black men who have sex with men are getting HIV at rates three times higher than their white counterparts, despite not engaging in riskier sexual behaviors. Could PrEP—the new prevention strategy in which HIV-negative people take a daily pill to avoid infection—turn this statistic around?

To address this question, the Young Black Gay Men’s Leadership Initiative (part of the National Black Gay Men’s Advocacy Coalition) will host a webinar on Tuesday, November 27, at 3:00 p.m. EST. Presenters include Isaiah Webster III, prevention manager with the National Alliance of State and Territorial AIDS Directors; Jonathan Paul Lucas, community program manager at FHI 360 for the HIV Prevention Trials Network and the Microbicides Trials Network; and Staci Bush, community medical scientist and patient advocate for Gilead Sciences.

Details of the event are excerpted below and available in full at NBGMAC.org.

Moving Forward: PrEP and Young Black Gay Men

November 27, 3:00 p.m. EST

In 2011, the CDC reported a 48% increase in new HIV infections among young Black gay, bisexual, same gender loving and other men who have sex with men (YBMSM); yet studies show that YBMSM are no more risky in terms of sexual risk behavior than their peers.

Research and community perspectives are proving over and over again the current model of prevention is inefficient at slowing down the growing HIV infection rates within the YBMSM community.…

On July 16, 2012, the US and Food and Drug Administration (FDA) approved a new option in the HIV prevention toolbox—Gilead’s Truvada for HIV prevention in uninfected adults at high risk of acquiring HIV through sex. This is the first ARV to be approved for HIV prevention in HIV-negative adults.

Join the YBGLI as they bring together experts in the field to explain this new option and answer your questions about this new prevention option….

Click here to register for this important webinar.



Comments are closed.